Pancreatic Cancer Research

ResearcherUniversitätsmedizin GöttingenActive in the last 2 years

Daniel Schaefer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2227-2456; OpenAlex author ID A5088869451. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 3

  1. Engineering Functional CLA-Targeting CAR Approaches for Pancreatic Ductal Adenocarcinoma Last author DOI 10.64898/2026.07.03.736395↗
  2. Combinatorial adapter targeting enables AND-gate activation of AdCAR T cells in pancreatic cancer but reveals donor-dependent activation thresholds Last author DOI 10.64898/2026.07.03.736407↗
  3. Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma. Co-author DOI 10.1038/s41467-021-21774-4↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Olaf Hardt · 3 shared papers, 2021–2026 · strength 0.81
  2. Camille Dourlens · 2 shared papers, 2026 · strength 0.71
  3. Janina Henze · 1 shared paper, 2021 · strength 0.10
  4. Wa’el Al Rawashdeh · 1 shared paper, 2021 · strength 0.10
  5. Diana Pinkert‐Leetsch · 1 shared paper, 2021 · strength 0.10
  6. Frauke Alves · 1 shared paper, 2021 · strength 0.10
  7. Jeannine Missbach‐Guentner · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.